Name the drug class to which canagliflozin belongs and explain why this drug is or is not a viable treatment option. (Wild card, LGS6.8.3 WFA6.8)
SGLT2 inhibitor; normally used in combo with metformin for diabetes (HbA1c>9.0), BUT not for pt. with eGFR less than 45 mL/min/1.73m2 (AE renal impairment)
Oops!
Check
Okay!
Check
15
Explain the pulmonary and renal mechanisms that compensate for alkalosis and acidosis. (SIGS 6.9b)
See image
Oops!
Check
Okay!
Check
seesaw
Swap points!
Oops!
seesaw
Swap points!
Okay!
fairy
Take points!
5
10
15
20
25
baam
Lose 10 points!
Oops!
15
Explain the pathophysiologic changes that occur in MCD and other etiologies of nephrotic syndrome. (SIGS6.8a)
MCD: LM: no changes; EM: effacement of podocyte foot processes; IF: negative; selective glomerular proteinuria; most common nephrotic syndrome in children